Quanta Therapeutics, Inc.
Funding rounds
3 counted as startup funding. Open the number of investors for the round's details.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Quanta Therapeutics, Inc. chose not to state its revenue in its newest notice of a funding round (Jun 2026).
SEC Form D · Jun 2026
The industry group it chose in its notices: Biotechnology.
SEC Form D · Jun 2026
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of Quanta Therapeutics, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Cameron Pitt | Executive officer | Jun 2026 |
| Derek Metzger | Executive officer | Jun 2026 |
| Perry Nisen | Executive officer | Jun 2026 |
| Leonardo Faoro | Executive officer | May 2023 |
| Cameron Pitt | Director | Jun 2026 |
| Maha Katabi | Director | Jun 2026 |
| Maria Fardis | Director | Jun 2026 |
| Perry Nisen | Director | Jun 2026 |
| Rajul Jain | Director | Jun 2026 |
| Ying Huang | Director | Jun 2026 |
| Arjun Goyal | Director | May 2023 |
| Samuel Saks | Director | May 2023 |